The DOI matches its Crossref record, with a small difference in title or year; 6 of the 6 references it cites were found in a registry or an index.
Cardiovascular Risk Factors in Confirmed Prediabetic Individuals: Does the Clock for Coronary Heart Disease Start Ticking Before the Onset of Clinical Diabetes?
Abstract
Although type II diabetes is associated with both microvascular and macrovascular complications, duration of diabetes and severity of glycemia are strongly associated only with the former. Since prediabetic individuals are hyperinsulinemic, and since hyperinsulinemia may be a cardiovascular risk factor, we hypothesized that prediabetic individuals might have an atherogenic pattern of risk factors even before the onset of clinical diabetes, thereby explaining the relative lack of an association of macrovascular complications with either glycemic severity or disease duration. We documented the cardiovascular risk factor status of 614 initially nondiabetic Mexican Americans who later participated in an 8-year follow-up of the San Antonio Heart Study, a population-based study of diabetes and cardiovascular disease. Individuals who were nondiabetic at the time of baseline examination, but who subsequently developed type II diabetes (ie, confirmed prediabetic subjects, n = 43), had higher levels of total and lowdensity lipoprotein cholesterol, triglyceride, fasting glucose and insulin, 2-hour glucose, body mass index, and blood pressure, and lower levels of high-density lipoprotein cholesterol than subjects who remained nondiabetic (n = 571). Most of these differences persisted after adjustment for obesity and/or level of glycemia, but were abolished after adjustment for fasting insulin concentration. When subjects with impaired glucose tolerance at baseline (n = 106) were eliminated, the more atherogenic pattern of cardiovascular risk factors was still evident (and statistically significant) among initially normoglycemic prediabetic subjects. These results indicate that prediabetic subjects have an atherogenic pattern of risk factors (possibly caused by obesity, hyperglycemia, and especially hyperinsulinemia), which may be present for many years and may contribute to the risk of macrovascular disease as much as the duration of clinical diabetes itself. (JAMA. 1990;263:2893-2898)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The risk of progressing from prediabetes to overt T2D are greatest for those persons with a history of GDM, strong family history of T2D, progressive increments in glycemia within the prediabetes range, and who meet criteria for a combination of IFG, IGT, or metabolic syndrome (any 2 out of 3).9,805,806”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [805]
In the citing paper
“In this regard, elevated TG and insulin resistance may both impair HDL function37-39 and predate the development of diabetes.40”
From Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor?: New Insights From the Framingham Offspring Study (2016) · cites this paper as [40]
In the citing paper
“High triglyceride levels that accompany either normal or impaired fasting glucose predict the development of T2DM, 166,167 and therefore, hypertriglyceridemic states should prompt surveillance to rule out T2DM.”
From Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2011) · cites this paper as [166]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Items 401–500 of 673
Liu, Y., Liu, L.-Y., Jia, Y., Sun, Y., & Ma, F. (2019) · Bioscience Reports · doi:10.1042/bsr20181852 · Cited by 16
RetractedPei, D., Kuo, S.-W., Wu, D., Lin, T., Hseih, M.-C., Lee, C., Hsu, W.-L., Chen, S.-P., Sheu, W. H., & Jc, L. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2005.00661.x · Cited by 16
Reappraisal of the pharmacologic approach to treatment of type 2 diabetes mellitus
Weissman, P. N. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02558-4 · Cited by 16
O’Neil, C. E., Nicklas, T. A., Suzuki, S., Myers, L., Johnson, C., & Berenson, G. S. (1997) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199712000-00005 · Cited by 16
Microalbuminuria: A Genetic Link Between Diabetes and Cardiovascular Disease?
Yudkin, J. S. (1992) · Annals of Medicine · doi:10.3109/07853899209167005 · Cited by 16
Genetic epidemiology of non‐insulin‐dependent diabetes
Valsania, P., & Micossi, P. (1994) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610100404 · Cited by 16
Papademetriou, V., Piller, L. B., Ford, C. E., Gordon, D., Hartney, T. J., Geraci, T. S., Reisin, E., Sumner, B., Wong, N. D., Nwachuku, C., et al. (2003) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2003.03163.x · Cited by 15
Cubeddu, L. X., Alfieri, A. B., & Hoffmann, I. (2007) · American Journal of Hypertension · doi:10.1038/ajh.2007.6 · Cited by 15
Kim, H., Lee, J. B., Kim, S., Jo, M., Kim, E. H., Hwang, J. Y., Bae, S. J., Jung, C. H., Lee, W. J., Park, J., et al. (2015) · Journal of Diabetes · doi:10.1111/1753-0407.12343 · Cited by 16
Effect of Family History of Type 2 Diabetes on White Blood Cell Count in Adult Women
Pannacciulli, N., Giorgino, F., Martina, R. A., Resta, O., GIORGINO, R., & Pergola, G. D. (2003) · Obesity Research · doi:10.1038/oby.2003.169 · Cited by 15
The metabolic syndrome in type 2 diabetes: When does it matter?
Wong, J., Molyneaux, L. M., Constantino, M., Twigg, S. M., & Yue, D. K. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00565.x · Cited by 15
Polycystic Ovarian Syndrome: the Next Cardiovascular Dilemma in Women?
Srikanthan, P., Korenman, S. G., & Davis, S. S. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.05.001 · Cited by 14
Lu, W., Resnick, H. E., Jablonski, K. A., Jain, A. K., Jones, K. L., Robbins, D. C., & Howard, B. V. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01137.x · Cited by 15
McKenney, J. M. (1993) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1993.tb02741.x · Cited by 15
Statin therapy for the treatment of diabetic dyslipidemia
Haffner, S. M. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.393 · Cited by 15
Self-citationClustering of Cardiovascular Risk Factors
Haffner, S. M. (1998) · Medical science symposia series · doi:10.1007/978-94-011-5022-4_27 · Cited by 15
Self-citationScreening for Diabetes: Can We Afford Not To Screen?
Nathan, D. M., & Herman, W. H. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-9-200405040-00017 · Cited by 15
Normalization of glucose in the intensive care unit: Does one size really fit all?*
Kaufman, S. T. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e318181129a · Cited by 14
Prevalence and risk factors for diabetic retinopathy in prediabetes in Asian Indians
Rajalakshmi, R., UmaSankari, G., Sivaprasad, S., Venkatesan, U., Kumpatla, S., Shanthirani, C. S., Viswanathan, V., & Mohan, V. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108131 · Cited by 14
Zheng, J., Gao, Y., Yuejuan, J., Zhou, X., Shi, Y., Li, Y., Wang, L., Wang, R., Li, M., Xiao, C., et al. (2014) · Frontiers of Medicine · doi:10.1007/s11684-014-0346-y · Cited by 14
Avilés-Santa, L. M., Salinas, K., ADAMS-HUET, B. A., & Raskin, P. (2006) · Journal of Investigative Medicine · doi:10.2310/6650.2005.05012 · Cited by 14
Petersen, J. L., Yow, E. S., AlJaroudi, W., Shaw, L. K., Goyal, A., McGuire, D. K., Peterson, E. D., & Harrington, R. A. (2010) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.109.864447 · Cited by 14
Eun, Y., Kang, S. G., & Song, S.-W. (2016) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2016.334 · Cited by 16
Crudele, A., Dato, S., Re, O. L., Maugeri, A., Sanna, P., Giallongo, S., Oben, J. A., Panera, N., Rango, F. D., Mosca, A., et al. (2021) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003123 · Cited by 13
Praveen, E. P., Kulshreshtha, B., Khurana, M. L., Sahoo, J., Gupta, N., Kumar, G., Ammini, A. C., & Knadgawat, R. (2011) · HORMONES · doi:10.14310/horm.2002.1293 · Cited by 13
Beijers, H. J. B. H., Henry, R. M. A., Bravenboer, B., Ferreira, I., Dekker, J. M., Nijpels, G., & Stehouwer, C. D. A. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2010.256 · Cited by 13
Simple risk score to detect rural Asian Indian (Bangladeshi) adults at high risk for type 2 diabetes
Bhowmik, B., Akhter, A., Ali, L., Ahmed, T., Pathan, F., Mahtab, H., Khan, A. K. A., & Hussain, A. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12344 · Cited by 13
Imoisili, O. E., & Sumner, A. E. (2009) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-009-0026-7 · Cited by 13
International spinal cord injury endocrine and metabolic extended data set
Bauman, W. A., Wecht, J. M., & Biering‐Sørensen, F. (2017) · Spinal Cord · doi:10.1038/sc.2016.164 · Cited by 13
Blanco-Rojo, R., Pérez‐Martínez, P., López-Moreno, J., Martínez-Botas, J., Delgado‐Lista, J., van-Ommen, B., Yubero‐Serrano, E. M., Camargo, A., Ordovás, J. M., Pérez‐Jiménez, F., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-12678-9 · Cited by 13
Latchan, Z., Seereeram, R., Kamalodeen, A., Sanchez, S. M., Deonarine, U., Sinanan, R., & Mungrue, K. (2010) · The British Journal of Diabetes · doi:10.1177/1474651410366553 · Cited by 14
Oral Glucose Tolerance Testing in Asymptomatic Obese Children: More Questions than Answers
Roman, R., & Zeitler, P. S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1993 · Cited by 13
Zamani, M. M., Nikbaf‐Shandiz, M., Aali, Y., Rasaei, N., Zarei, M., Shiraseb, F., & Asbaghi, O. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1084084 · Cited by 14
Novielli, N. M., & Jackson, D. N. (2014) · Acta Physiologica · doi:10.1111/apha.12297 · Cited by 12
Jun, J. E., Jeong, I., Yu, J. M., Kim, S. R., Lee, I. K., Han, K. A., Choi, S. H., Kim, S., Park, H. K., Mok, J., et al. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0265 · Cited by 12
Harada, K., Yahata, T., Onizuka, M., Ibrahim, A. A., Kikkawa, E. F., Miyata, T., & Ando, K. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.04.017 · Cited by 11
Chronic hyperinsulinernia inhibits platelet-activating factor (PAF) biosynthesis in the rat kidney
Kudoloa, G. B., Koopmans, S. J., Haywood, J. R., & DeFronzo, R. A. (1997) · Journal of Lipid Mediators and Cell Signalling · doi:10.1016/s0929-7855(96)00565-2 · Cited by 12
Diabetes mellitus and coronary heart disease ‐ from prevention to intervention: Part I
Farouque, H. M. O., O’Brien, R. C., & Meredith, I. T. (2000) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.2000.tb00837.x · Cited by 12
The effects of errors in lipid measurement and assessment
Cooper, G. R., Myers, G. L., Kimberly, M. M., & Waymack, P. P. (2002) · Current Cardiology Reports · doi:10.1007/s11886-002-0114-5 · Cited by 12
Physical Activity and Type 2 Diabetes
Bhaskarabhatla, K. V., & Birrer, R. B. (2004) · The Physician and Sportsmedicine · doi:10.3810/psm.2004.01.80 · Cited by 13
Assessment of diabetes screening by general practitioners in France: the EPIDIA Study
Cogneau, J., Balkau, B., Weill, A., Liard, F., & Simon, D. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01877.x · Cited by 12
The aging of the cardiovascular system: When should children be treated like adults?
Gidding, S. S. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.126922 · Cited by 12
Shalitin, S., Tauman, R., Meyerovitch, J., & Sivan, Y. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0583-1 · Cited by 11
Prevention of coronary heart disease Part I. Primary prevention
Liesbon, P. R., & Amsterdam, E. A. (1999) · Disease-a-Month · doi:10.1016/s0011-5029(99)90016-0 · Cited by 11
Apolipoproteins A-I, B, and C-III and Obesity in Young Adult Cherokee
Wang, W., Blackett, P. R., Khan, S. H., & Lee, E. T. (2017) · Journal of Lipids · doi:10.1155/2017/8236325 · Cited by 11
Yunn, N.-O., Kim, J. J., Kim, Y., Leibiger, I. B., Berggren, P., & Ryu, S. H. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.12.005 · Cited by 11
Tanaka, S., Fujioka, Y., Tsujino, T., Ishida, T., & Hirata, K. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0822-5 · Cited by 11
Varga, T. V., Liu, J., Goldberg, R. B., Chen, G., Dagogo-Jack, S. E., Lorenzo, C., Mather, K. J., Pi-Sunyer, X., Brunak, S., & Temprosa, M. G. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001953 · Cited by 12
Lipid Management Reduces Cardiovascular Complications in Individuals With Diabetes and Prediabetes
Aparna, G., Gregory, F., & David, G. (2006) · Preventive Cardiology · doi:10.1111/j.1520-037x.2000.4071.x · Cited by 11
Jiang, Y.-D., Yen, C., Chou, W.-J., Kuo, S., Lee, K., Chiu, K. C., & Chuang, L. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01715.x · Cited by 11
THE DIAGNOSIS AND CLASSIFICATION OF DIABETES MELLITUS IN NONPREGNANT ADULTS
Herman, W. H., & Wareham, N. J. (1999) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(05)70129-9 · Cited by 11
Management of Hyperlipidemia in Diabetes Mellitus
Dunn, F. L. (1992) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30223-8 · Cited by 11
Conway, B. N., Fischl, A. F. R., Murray, P. J., & Weber, K. (2014) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s68283 · Cited by 11
Huang, C.-L., Chang, H., Chang, J.-B., Chen, J.-H., Lin, J., Wu, C., Pei, D., Hung, Y.-J., Lee, C.-H., Chen, Y.-L., et al. (2015) · QJM · doi:10.1093/qjmed/hcv204 · Cited by 10
Guo, F., Zhou, T., Tang, J., Dong, M., & Wei, Q. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0865-1754 · Cited by 10
Ishii, H. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13799 · Cited by 11
Biochemical and genetic studies on cardiometabolic syndrome
Simon, A. S., Roy, D., Jayapal, V., & Vijayakumar, T. (2010) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-010-0030-1 · Cited by 10
Diabetes and Cardiovascular Disease
Bitzur, R. (2011) · Diabetes Care · doi:10.2337/dc11-s256 · Cited by 10
Wang, M., Han, Y., Li, Q., Guo, L., Yang, Y., Wang, W., & Zhang, J. (2012) · Journal of International Medical Research · doi:10.1177/147323001204000410 · Cited by 10
Davidson, M., Hu, T., Sain, G., Hoar, B. M., Stevenson, C., & Hoogwerf, B. J. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00912.x · Cited by 10
Microvascular dysfunction: Determinants and treatment, with a focus on hyperglycemia
Houben, A. J. H. M., & Stehouwer, C. D. A. (2020) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2020.100073 · Cited by 10
Clinical use of thiazolidinediones: recommendations
Abrahamson, M. J. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.08.016 · Cited by 10
Wang, Y. (2010) · Wiley eBooks · doi:10.1002/9781444323351.ch18 · Cited by 10
Alshuweishi, Y., Almufarrih, A. A., Abudawood, A., Alfayez, D. I., Alkhowaiter, A. Y., AlSudais, H., & Almuqrin, A. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14090980 · Cited by 13
Mokhtar, S., Viljoen, J., Kallen, C., Berendschot, T. T. J. M., Dagnelie, P. C., Albers, J. D., Soeterboek, J., Scarpa, F., Colonna, A., van der Heide, F. C. T., et al. (2024) · Environmental Health · doi:10.1186/s12940-024-01110-1 · Cited by 9
Rydén, L., Waeber, B., Ruilope, L. M., Mancia, G., Volpe, M., Holzgreve, H., Mogensen, C. E., & Laurent, S. (2008) · Blood Pressure · doi:10.1080/08037050802513387 · Cited by 9
Dell’Omo, G., Penno, G., Prato, S. D., Mariani, M., & Pedrinelli, R. (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.142 · Cited by 8
Tsave, O., Gabriel, C., Kafantari, M., Yavropoulou, M. P., Yovos, J. G., Raptopoulou, C. P., Psycharis, V., Terzis, A., Mateescu, C., & Salifoglou, A. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2018.02.001 · Cited by 9
Semenkovich, C. F., Goldberg, A. C., & Goldberg, I. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00037-x · Cited by 14
Dyslipidemia in Noninsulin-Dependent Diabetes Mellitus
Kosmiski, L. A., & Eckel, R. H. (1997) · Humana Press eBooks · doi:10.1007/978-1-4757-3906-0_9 · Cited by 9
Role of insulin and proinsulin in diabetic vascular disease
Wareham, N. J., Byrne, C. D., & Hales, C. N. (1995) · Metabolism · doi:10.1016/0026-0495(95)90225-2 · Cited by 9
Detection and Management of Diabetes in England: Results from the Health Survey for England
Xiao, M., & O’Neill, C. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0300-5 · Cited by 8
Preuss, H. G., Kaats, G. R., Mrvichin, N., Bagchi, D., & Swaroop, A. (2018) · Journal of the American College of Nutrition · doi:10.1080/07315724.2017.1413962 · Cited by 8
Zhu, X., Chen, Z., Yang, P., Liu, L., Wu, L., & Wang, Y. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.07.007 · Cited by 8
The metabolic syndrome: evolving evidence that thiazolidinediones provide rational therapy
Wyne, K. L. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00522.x · Cited by 8
Miyazaki, Y., Furugen, M., Akasaka, H., Saitoh, S., & Miura, T. (2012) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2012.23044 · Cited by 8
La prevención cardiovascular en la diabetes mellitus: un reto multifactorial
Pedro‐Botet, J., Chillarón, J. J., Benaiges, D., & Roux, J. A. F. (2015) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2015.10.003 · Cited by 9
Kumpatla, S., Michael, C., & Viswanathan, V. (2011) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2012.05.003 · Cited by 10
Genetic determinants of diabetes and atherosclerosis
Mitchell, B. D., & Imumorin, I. G. (2002) · Current Atherosclerosis Reports · doi:10.1007/s11883-002-0019-1 · Cited by 8
Astbury, N. M., Ripullone, K., Ramakrishnan, R., Woodward, M., & Hirst, J. E. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70210 · Cited by 8
Guerreiro, V. A., Maia, I., Neves, J. S., Salazar, D. A., Ferreira, M. J., Mendonça, F. M., Silva, M. M., Borges‐Canha, M., Viana, S., Costa, C. F., et al. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00865-2 · Cited by 8
Serum AGEs and sRAGE levels are not related to vascular complications in patients with prediabetes
Gateva, A., Assyov, Y. S., Tsakova, A. D., & Kamenov, Z. A. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.01.014 · Cited by 7
A demonstration area for type 2 diabetes prevention in Barranquilla and Juan Mina (Colombia)
Acosta, T., Barengo, N. C., Arrieta, A., Ricaurte, C., & Tuomilehto, J. O. (2018) · Medicine · doi:10.1097/md.0000000000009285 · Cited by 7
Hypoglycemic effects of submerged culture of Ceriporia lacerata mycelium
Shin, E. J., Kim, J.-E., Kim, J., Park, Y. M., Yoon, S. K., Jang, B., Lee, S., & Kim, B.-C. (2015) · Korean Journal of Food Preservation · doi:10.11002/kjfp.2015.22.1.145 · Cited by 7
Dyslipidemia in Type 2 Diabetes and the Effects of Thiazolidinediones
Bell, D. (2003) · The Endocrinologist · doi:10.1097/01.ten.0000098612.88907.4b · Cited by 8
Applying laws of biology to diabetes with emphasis on metabolic syndrome
Houck, P. D., & Oliveira, J. M. F. D. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2012.11.019 · Cited by 7
Workshop IX—Lipids, insulin, diabetes
Simonson, C.-C. D. C., & Dzau, V. J. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90046-z · Cited by 7
Ruderman, N. B., & Shulman, G. I. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00044-7 · Cited by 7
Prevention of Type 2 Diabetes Mellitus
Simpson, R. W., Tuomilehto, J. O., Lindström, J., Shaw, J. E., & Zimmet, P. (2003) · Wiley eBooks · doi:10.1002/0470862092.d1118 · Cited by 7
Hu, F. B. (2011) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/1741826711421689 · Cited by 7
Karnebeek, K., Rijks, J. H. J., Dorenbos, E., Gerver, W. M., Plat, J., & Vreugdenhil, A. C. E. (2020) · Nutrients · doi:10.3390/nu12051228 · Cited by 6
Faggiano, A., Bursi, F., Santangelo, G., Tomasi, C., Sforza, C., Faggiano, P. M., & Carugo, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071343 · Cited by 7
Chen, K., Zheng, J., Shao, C., Zhou, Q., Yang, J., Huang, T., & Tang, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.965995 · Cited by 6
Ahmed, D., Sharma, M., & Pillai, K. K. (2011) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2011.00960.x · Cited by 6
Integrating lipid screening with ideal cardiovascular health assessment in pediatric settings
Blackett, P. R., George, M. M., & Wilson, D. P. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.08.009 · Cited by 7
de Oliveira, C. M., Tureck, L. V., Alvares, D., Liu, C., Horimoto, A. R. V. R., Alvim, R. D. O., Krieger, J. E., & Pereira, A. C. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0512-0 · Cited by 6
Ruderman, N. B., & Shulman, G. I. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00043-3 · Cited by 7
Wang, J., Zou, T., Yang, H., Gong, Y., Xie, X. J., Liu, H., & Liao, D.-F. (2015) · Genetics and Molecular Research · doi:10.4238/2015.august.3.5 · Cited by 6
Benefits of early initiation of insulin therapy to long-term goals in type 2 diabetes mellitus
Vinik, A. I. (2006) · Insulin · doi:10.1016/s1557-0843(06)80003-5 · Cited by 6
Karakitsos, D., Patrianakos, A. P., Parthenakis, F. I., Malliaraki, N. E., Nikitovic, D., Kyriazis, J., Karabinis, A., Groothoff, J. W., de Groot, E., Fourtounas, C., et al. (2007) · ASAIO Journal · doi:10.1097/mat.0b013e318050d607 · Cited by 6
Metadata
- Authors
- Haffner, S. M.
- Corresponding author
- Haffner, Steven M.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1990-06-06
- Volume
- 263
- Issue
- 21
- Pages
- 2893
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4297681290
- Cited by
- 668
- References
- 0
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 14 · 2023: 9 · 2022: 18 · 2021: 12 · 2020: 23 · 2019: 15 · 2018: 16 · 2017: 14 · 2016: 17 · 2015: 25 · 2014: 21 · 2013: 16 · 2012: 22
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- prediabetes, type 2 diabetes, cardiovascular risk factors, hyperinsulinemia, atherogenic lipid profile, impaired glucose tolerance, macrovascular complications, Mexican Americans, San Antonio Heart Study, fasting insulin, obesity, disease duration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review